Selective antitumor agent

Details Selective antitumor agent Selective antitumor agent

A - Human Necessities

61

K

167/129, 167/139

A61K 39/395 (2006.01) A61K 35/78 (1985.01) A61K 37/00 (1985.01)

Patent

CA 1202897

ABSTRACT OF THE DISCLOSURE This invention relates to a selective antitumor agent consisting of a special carrier portion and a voluntary antitumor ingredient. The carrier portion is a monoclonal antibody (MoAb) which is produced by a hybri- doma formed by cell fusion of two kinds of animal cells, one of which is an animal cell sensitized by human tumor cell such as spleen cell of BALB/c mouse and another of which is another animal cell such as mouse myeloma cell. The antibody is isolated from the hybridoma and chemical- ly bound with the voluntary antitumor ingredient such as an alkylating agent, an antimetabolic agent, a cytotoxic antibiotic protein or polypeptide, toxin, or alkaloid. The resultant medicine-MoAb conjugate selectively binds with specific tumor cells or tissue having corresponding antigens and the medicine selectively attacks said cells or tissue as its target.

418956

Affiliated with

Also associated with

Rating

Selective antitumor agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective antitumor agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective antitumor agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1331855